Japan & Sun Pharma
5 shared events · Importance 3 · Last updated Jul 19, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Japan: AVT05, AVT06, and AVT03 have already been approved in Japan>>>, indicating their global market presence.
Sun Pharma: Sun Pharma>>> is partnered with Alvogen>>> for the commercialization of AVT05 and AVT06. The resubmission of BLAs by Alvogen>>> is a positive development for Sun Pharma>>> as it moves closer to potentially commercializing these biosimilars.
Jun 04, 2026 · 10 articles
Business
Japan: Positive outcomes from the India-Japan Summit contributed to lifted sentiment in domestic markets.
Sun Pharma: Sun Pharma was among the winning stocks, contributing to the overall market gains.
Jul 03, 2026 · 7 articles
International
Japan: Nikkei 225 declined over 4% amid global risk-off sentiment.
Sun Pharma: Gained as a top gainer.
Jul 06, 2026 · 105 articles
Domestic
Japan: Japan's Nikkei 225 climbed 3%, contributing to the positive Asian market sentiment.
Sun Pharma: Among laggards, possibly due to profit booking.
Aug 03, 2026 · 20 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Japan and Sun Pharma interact across events, view sentiment trends, and discover connected entities.
Open Dashboard